Literature DB >> 18854957

The influence of sphingosine-1-phosphate receptor signaling on lymphocyte trafficking: how a bioactive lipid mediator grew up from an "immature" vascular maturation factor to a "mature" mediator of lymphocyte behavior and function.

Michael D Davis1, John H Kehrl.   

Abstract

Since the initial observations that highlighted the importance of lymphocyte trafficking for immune responses, the pathways utilized by B and T lymphocytes to recirculate and properly position themselves have been intensely studied. Most of the chemoattractants along with their cognate receptors that affect lymphocyte trafficking have been identified. Some of their functions are promotion of lymphocyte ingress into immune organs, localization of cells to specific regions within those organs, maintenance of lymphocyte basal motility in immune organs, facilitation of lymphocyte egress from these organs, and control of migration and homing of lymphocytes in the periphery. Since the seminal discovery that agonism of sphingosine-1-phosphate receptors evokes changes in lymphocyte homing and trafficking, considerable effort has been undertaken to characterize the mechanism utilized by these receptors to influence lymphocyte behavior. This review will focus on the influence of sphingosine-1-phosphate signaling system on lymphocyte localization, egress from lymph organs, and its effects on the lymphatic vasculature.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18854957     DOI: 10.1007/s12026-008-8066-5

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  110 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

2.  Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft.

Authors:  L Zhang; T Zhu; E W Sun; S Q Shen; Z L Min; Z K Chen
Journal:  Transplant Proc       Date:  2003-02       Impact factor: 1.066

3.  FTY720 treatment of kidney transplant patients: a differential effect on B cells, naïve T cells, memory T cells and NK cells.

Authors:  Leonard M B Vaessen; Nicole M van Besouw; Wendy M Mol; Jan N M Ijzermans; Willem Weimar
Journal:  Transpl Immunol       Date:  2006-03-24       Impact factor: 1.708

4.  The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function.

Authors:  A John MacLennan; Shannon J Benner; Anastasia Andringa; Alicia H Chaves; Joanna L Rosing; Rachel Vesey; Adam M Karpman; Samantha A Cronier; Nancy Lee; Larry C Erway; Marian L Miller
Journal:  Hear Res       Date:  2006-08-30       Impact factor: 3.208

5.  The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.

Authors:  Steven W Paugh; Shawn G Payne; Suzanne E Barbour; Sheldon Milstien; Sarah Spiegel
Journal:  FEBS Lett       Date:  2003-11-06       Impact factor: 4.124

6.  Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells.

Authors:  Victor E Nava; John Peyton Hobson; Shvetha Murthy; Sheldon Milstien; Sarah Spiegel
Journal:  Exp Cell Res       Date:  2002-11-15       Impact factor: 3.905

7.  FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury.

Authors:  Duska Dragun; Torsten Böhler; Melina Nieminen-Kelhä; Johannes Waiser; Wolfgang Schneider; Hermann Haller; Friedrich C Luft; Klemens Budde; Hans-Hellmut Neumayer
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

8.  FTY720 application following isolated warm liver ischemia improves long-term survival and organ protection in a mouse model.

Authors:  C P Kaudel; M Frink; M van Griensven; U Schmiddem; C Probst; S Bergmann; C Krettek; J Klempnauer; M Winkler
Journal:  Transplant Proc       Date:  2007-03       Impact factor: 1.066

9.  FTY720 mediates apoptosis-independent lymphopenia in human renal allograft recipients: different effects on CD62L+ and CCR5+ T lymphocytes.

Authors:  Torsten Böhler; Johannes Waiser; Manuela Schütz; Duska Dragun; Hans-H Neumayer; Klemens Budde
Journal:  Transplantation       Date:  2004-05-15       Impact factor: 4.939

10.  Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium.

Authors:  Jun Kunisawa; Yosuke Kurashima; Morio Higuchi; Masashi Gohda; Izumi Ishikawa; Ikuko Ogahara; Namju Kim; Miki Shimizu; Hiroshi Kiyono
Journal:  J Exp Med       Date:  2007-09-17       Impact factor: 14.307

View more
  5 in total

1.  PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate.

Authors:  Brian M Barth; Sriram S Shanmugavelandy; James M Kaiser; Christopher McGovern; Erhan İ Altınoğlu; Jeremy K Haakenson; Jeremy A Hengst; Evan L Gilius; Sarah A Knupp; Todd E Fox; Jill P Smith; Timothy M Ritty; James H Adair; Mark Kester
Journal:  ACS Nano       Date:  2013-02-14       Impact factor: 15.881

Review 2.  Export and functions of sphingosine-1-phosphate.

Authors:  Roger H Kim; Kazuaki Takabe; Sheldon Milstien; Sarah Spiegel
Journal:  Biochim Biophys Acta       Date:  2009-03-04

3.  Sphingosine-kinase 1 and 2 contribute to oral sensitization and effector phase in a mouse model of food allergy.

Authors:  Susanne C Diesner; Ana Olivera; Sandra Dillahunt; Cornelia Schultz; Thomas Watzlawek; Elisabeth Förster-Waldl; Arnold Pollak; Erika Jensen-Jarolim; Eva Untersmayr; Juan Rivera
Journal:  Immunol Lett       Date:  2011-10-14       Impact factor: 3.685

Review 4.  S1P-S1PR1 Signaling: the "Sphinx" in Osteoimmunology.

Authors:  Lan Xiao; Yinghong Zhou; Thor Friis; Kenneth Beagley; Yin Xiao
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

5.  Hypertrophy of infected Peyer's patches arises from global, interferon-receptor, and CD69-independent shutdown of lymphocyte egress.

Authors:  O Schulz; M Ugur; M Friedrichsen; K Radulovic; J-H Niess; S Jalkanen; A Krueger; O Pabst
Journal:  Mucosal Immunol       Date:  2013-12-18       Impact factor: 7.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.